Significance of lymphocyte fatty acid changes in chronic renal failure

Nephron

Volumn 73, Issue 4, 1996, Pages 704-706

  Kalofoutis, A ^a   Nicolaidou Politis, V ^a   Bouloukos, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Chronic renal failure; Fatty acids; Hemodialysis; Lymphocytes; Maintenance

Indexed keywords

ARACHIDONIC ACID; FATTY ACID; LINOLEIC ACID; LYSOSOME ENZYME; STEARIC ACID;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE; LYMPHOCYTE MEMBRANE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

ADULT; FATTY ACIDS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LYMPHOCYTES; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0029739359     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189165     Document Type: Article

References (22)

1. Lindner A. Charra B. Sherrard D. Scribner B: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974:290: 697-701.
2. Merril J. Brigham PB: Cardiovascular problems in patients on long term hemodialysis. JAMA 1974;228:1149-1151.
3. Spencer ES: Atherosclerosis in dialysis and renal transplant patients. Lancet 1980;i:591-592.
4. Seligmann M: B-cell and T-cell markers in lymphoid proliferations. N Engl J Med 1974:290: 1483-1486.
5. Capetanakis J, Tsambaos D, Kalofoutis A: A study of leukocytes phospholipid composition in mycosis fungoides. Dermalologica 1974; 151:85-89.
6. Kalofoutis A. Stratakis N: A possible relation between lymphocyte phospholipid fluctuations and immune response. IRCS Med Sci 1978;6: 45.
7. Kalofoutis A, Koutsclinis A, Dionvsiou-Aster-iou A. Miras C: The significance of lymphocyte lipid changes after smoking hashish. Acta Pharmacol Toxicol 1978:13:84-85.
8. McCosh EJ. Solangi K. Rivers JM. Goodman A: Hypertriglyceridemia in patients with chronic renal failure. Am J Clin Nutr 1975;28: 1036-1043.
9. Bagdade JD, Jec E, Wilson DE, Shafrir E: Hypcrlipidemia in renal failure: Studies of plasma lipoproteins, hepatic triglyceride production and tissue lipoprotein lipase in a chronically uremic rat model. J Lab Clin Med 1978;91:176-186.
10. Chan MK. Varghesc Z. Moorhead JF: Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int 1981;625-637.
11. Logan RL. Ricmcrsma RA, Thompson M, Oliver MF. Olsson AG. Walldius G. Rossner S, Kaijcr L. Callmer F. Carlson LA, Lockerbie L. Lutz W: Risk factors for ischaemic heart disease in normal men aged 40, Edinburgh. Stockholm Study. Lance 1978;i:949-955.
12. Paul R. Ramesha CS. Ganguly J: On the mechanism of hypocholestérolémie effects of polyunsaturated lipids. Adv Lipid 1980; 17:155-171.
13. Dodge JT. Phillips GB: Composition of phospholipids and phospholipid fatty acids and aldehydes in human red cells. J Lipid Res 1967; 8:667-675.
14. Meade C, Mertin J: Fatty acids and immunity. Adv Lipid Res 1978;16:127-165.
15. Kalofoulis A: Specific lymphocyte phospholipid changes in chronic renal failure. Clin Chem 1980;26:247-249.
16. Zaki A. El-Hcfni S, El-Banawi S, Tahoun M. Moghari Th, Abaza M. Kandil M: Studies on fatty acid pattern in chronic renal failure. Bio-chim Clin 1988;12:1365-1370.
17. Meissner BR. Lindstom ED. Williams RC: Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus. J Clin Invest 1973.,52:3046-3050.
18. Reddy MM. Goh KO. Ccstero RVM: T and B lymphocytes in patients with chronic renal disease on hemodialysis. Experientia 1975:31: 980-983.
19. Mackie RS, Less FR, Cocbram R. De Suca M: Lymphocyte abnormalities in mycosis fun-goidcs. BrJ Dermatol 1976:94:173-178.
20. Goodwin JS. Ccuppens J: Regulation of the immune response by prostaglandins. J Clin Immunol 1983;3:295-315.
21. Schreiner GF. Flyc W, Brunt E. Korber K. Lef-kowith JB: Essential fatty acid depletion of renal allografts and prevention of rejection. Science 1988;240:1032-1033.
22. Hwang D: Essential fatty acids and immunity. FASEBJ 1989;3:2052-2061.